dactinomycin has been researched along with Bone Cancer in 202 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 89 (44.06) | 18.7374 |
| 1990's | 55 (27.23) | 18.2507 |
| 2000's | 37 (18.32) | 29.6817 |
| 2010's | 15 (7.43) | 24.3611 |
| 2020's | 6 (2.97) | 2.80 |
| Authors | Studies |
|---|---|
| Kube, P; Mangum, DS; Parisio, K; Powell, J | 1 |
| Bompas, E; Brugières, L; Castex, MP; Chevreau, C; Cleirec, M; Corvest, V; Duranteau, L; Entz-Werle, N; Filhon, B; Flandrin, J; Fresneau, B; Gaspar, N; Gentet, JC; Guimard, G; Jimenez, M; Laurence, V; Le Deley, MC; Lervat, C; Mansuy, L; Marec-Bérard, P; Pacquement, H; Pondrom, M; Rousset-Jablonski, C; Saumet, L; Tabone, MD; Taque, S; Toulmonde, M; Verité, C | 1 |
| Brennan, B; Fenwick, N; Gaspar, N; Gelderblom, H; Kirton, L; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
| Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A | 1 |
| Anderton, J; Brennan, B; Evans, A; Fenwick, N; Fernández-Pinto, M; Gaspar, N; Gelderblom, H; Kaiser, S; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
| Chin, M; Hosono, A; Kawai, A; Koga, Y; Mugishima, H; Okita, H; Ozaki, T; Sano, H; Sumi, M; Watanabe, H; Yokoyama, R | 1 |
| Csikos, C; Hegedűs, C; Kiss, A; Polgár, Z; Regdon, Z; Virág, L | 1 |
| Burchill, SA; Jabri, S; Roundhill, EA | 1 |
| Bendinelli, P; Desiderio, MA; Locatelli, A; Maroni, P; Matteucci, E | 1 |
| Cai, HQ; Li, YC; Wang, ZG; Xu, YL; Yang, J | 1 |
| Brennan, B; Craft, A; Dirksen, U; Hjorth, L; Judson, I; Juergens, H; Ladenstein, R; Le Deley, MC; Le Teuff, G; Lewis, I; Marec-Bérard, P; Michon, J; Oberlin, O; Paulussen, M; Ranft, A; van den Berg, H; Wheatley, K; Whelan, J | 1 |
| Bilska, K; Chaber, R; Drabko, K; Pogorzała, M; Połczyńska, K; Raciborska, A; Rodriguez-Galindo, C; Rogowska, E; Sobol, G; Wożniak, W; Wyrobek, E | 1 |
| Agarwala, S; Bakhshi, S; Biswas, B; Deo, SV; Khan, SA; Mohanti, BK; Rastogi, S; Sharma, MC; Shukla, NK; Vishnubhatla, S | 1 |
| Aoki, Y; Araki, N; Hamada, K; Imura, Y; Joyama, S; Kakunaga, S; Naka, N; Obata, H; Takenaka, S; Ueda, T; Yoshikawa, H | 1 |
| Cassoni, A; Craft, AW; Douglas, C; Dunst, J; Grimer, R; Hackshaw, A; Hunold, A; Jürgens, H; Köhler, G; Ladenstein, R; Lewis, I; McTiernan, A; Paulussen, M; Poremba, C; Schuck, A; Spooner, D; van den Berg, H; Whelan, J; Winkelmann, W; Zoubek, A | 1 |
| Kawai, G; Matsuhashi, A; Nagano, A; Ohno, T; Saitou, M; Shimizu, K; Takigami, I; Wakahara, K; Yamada, K; Yamamoto, T | 1 |
| Brady, MS; Brown, K; Fisher, C; Marx, W; Patel, A | 1 |
| Arndt, CA; Bernstein, M; Devidas, M; Dickman, P; Gebhardt, M; Goorin, A; Granowetter, L; Grier, HE; Healey, J; Krailo, M; Leavey, P; Marcus, K; Marina, N; Meyer, J; Miser, J; Perlman, E; Sailer, S; Shamberger, RC; Wang, C; Womer, R | 1 |
| Heinen, RC; Merks, JH; van den Berg, H; van der Pal, HJ | 1 |
| Bacci, G; Balladelli, A; Briccoli, A; Di Fiore, M; Ferrari, C; Palmerini, E; Rocca, M; Salone, M | 1 |
| Bölling, T; Dirksen, U; Ernst, I; Jürgens, H; Ranft, A; Willich, N | 1 |
| Alberghini, M; Alvegard, TA; Bacci, G; Barbieri, E; Brach Del Prever, A; Capanna, R; Carli, M; Fagioli, F; Ferrari, S; Gandola, L; Luksch, R; Mapelli, S; Mercuri, M; Picci, P; Prete, A; Smeland, S; Sundby Hall, K; Tamburini, A; Tienghi, A; Wiebe, T | 1 |
| Feng, F; Geng, S; Wan, X; Wang, T; Xiang, Y | 1 |
| Cho, Y; Choi, Y; Chung, SH; Jung, GH; Kim, JD; Kim, JY | 1 |
| Cho, J; Cho, WH; Jeon, DG; Kim, DH; Kim, MS; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Lim, JS; Song, WS; Yoo, JY | 1 |
| Ash, S; Cohen, IJ; Feinmesser, M; Kornreich, L; Kuperman, AA; Yaniv, I | 1 |
| Andersen, CY; Birkebæk, NH; Clausen, N; Ernst, E; Kjærsgaard, M | 1 |
| Bao, CF; Li, XH; Yang, LM | 1 |
| Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ | 2 |
| Ayala, AG; Devidas, M; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, MB; Helman, LJ; Link, MP; Schwartzentruber, DJ | 1 |
| Graf, N; Hempel, L; Lemmer, A; Sauerbrey, A; Weirich, A; Zintl, F | 1 |
| ROCHLIN, DB | 1 |
| DIPAOLO, JA; DOWD, JE; WATNE, AL | 1 |
| NAHUM, AM | 1 |
| Goto, T; Hozumi, T; Kobayashi, H; Kondo, T; Kosaku, H | 1 |
| Billups, CA; Davidoff, AM; Krasin, MJ; Kun, LE; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
| Akansel, G; Arisoy, AE; Calişkan, M; Corapcioglu, F; Dillioğlugil, O; Sarper, N | 1 |
| Bashir, H; Crom, D; Hudson, MM; Jones, D; Metzger, M; Mulcahey, J | 1 |
| Mai, WY; Nguyen, TX; Paulino, AC; Teh, BS; Wen, BC | 1 |
| Katski, K; Kołłataj, B; Kołłataj, W; Majewski, M; Pijanowska, M; Sikora, P; Zajaczkowska, M | 1 |
| Bernstein, M; Chen, Z; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, M; Laurie, F; Miser, JS; Tarbell, NJ; Yock, TI | 1 |
| Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ | 1 |
| Hetzel, T; Losek, J; Reid, SR | 1 |
| Kawakami, M; Kawase, K; Kobayashi, T; Morikawa, T; Nogi, H; Suzuki, M; Tabei, I; Toriumi, Y; Uchida, K | 1 |
| Bacci, G; Barbieri, E; Bertoni, F; Colangeli, M; Di Bella, C; Donati, D; Ferrari, S; Mercuri, M; Yin, J | 1 |
| Boven, E; Meijer, OW; Smorenburg, CH; van Groeningen, CJ; Visser, M | 1 |
| Bacci, G; Balladelli, A; Bertoni, F; Briccoli, A; Ferrari, S; Forni, C; Longhi, A; Mercuri, M; Picci, P; Serra, M | 1 |
| Barbieri, S; Derenzini, M; Donati, G; Govoni, M; Mazzini, G; Montanaro, L; Nardi-Pantoli, A; Treré, D; Vici, M | 1 |
| Goto, T; Hozumi, T; Kondo, T; Nakada, I; Okuma, T | 1 |
| Blondet, R; Bouffet, E; Brunat-Mentigny, M; Chauvot, P; Moyen, B; Philip, T | 1 |
| Jürgens, H | 1 |
| Cacavio, A; Caparros, B; Huvos, AG; Kosloff, C; Lane, JM; Marcove, RC; Mehta, B; Nirenberg, A; Rosen, G; Urban, C | 1 |
| Horrig, C; Ribeiro-Ayeh, J; Walther, A | 1 |
| Beck, J; Beck, W; Beron, G; Brandeis, W; Ebell, W; Erttmann, R; Göbel, U; Havers, W; Henze, G; Hinderfield, L; Höcker, P; Jobke, A; Jürgens, H; Kabisch, H; Kotz, R; Landbeck, G; Preusser, P; Prindull, G; Ramach, W; Ritter, J; Salzer-Kuntschik, M; Sekera, J; Treuner, J; Winkler, K; Wüst, G | 1 |
| Beck, J; Beck, W; Beron, G; Brandeis, W; Ebell, W; Erttmann, R; Göbel, U; Kotz, R; Salzer-Kuntschik, M; Winkler, K | 1 |
| Carton, P; Deméocq, F; Lemerle, J; Oberlin, O; Patte, C; Sarrazin, D | 1 |
| Woźniak, W | 1 |
| Donaldson, MH; Foulkes, M; Newton, WA; Ragab, AH; Ruymann, FB | 1 |
| Woodhead, PJ | 1 |
| Burgert, EO; Gehan, EA; Kissane, J; Nesbit, M; Perez, CA; Pritchard, DJ; Tefft, M; Vietti, T | 1 |
| Burgert, EO; Gehan, EA; Kissane, J; Nesbit, ME; Perez, CA; Pritchard, DJ; Tefft, M; Vietti, TJ | 2 |
| Bartolucci, AA; Lowenbraun, S; Presant, CA; Smalley, RV | 1 |
| Pant, GC; Sahni, K; Sanyal, B; Srivastava, TP; Tuli, SM | 1 |
| Benjamin, RS; Bodey, GP; Burgess, MA; Murphy, WK; Sinkovics, JG; Yap, BS | 1 |
| Landbeck, G; Winkler, K | 1 |
| Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M | 1 |
| Dunst, J; Jürgens, H; Pape, H; Paulussen, M; Rübe, C; Sauer, R; Winkelmann, W | 1 |
| Link, MP | 1 |
| Bielack, SS; Delling, G; Jürgens, H; Kotz, R; Salzer-Kuntschik, M; Winkler, K | 1 |
| Krailo, M; Miser, JS | 1 |
| Avella, M; Bacci, G; Casadei, R; Cazzola, A; Ferrari, S; Lari, S; Monti, C; Picci, P; Prever, BA; Ruggieri, P | 1 |
| Heller, G; Meyers, PA; Vlamis, V | 1 |
| Delepine, G; Delepine, N; Desbois, JC | 1 |
| Contesso, G; Edeline, V; Kalifa, C; Lemerle, J; Razafindrakoto, H; Valteau, D; Vanel, D; Vassal, G | 1 |
| Ekert, H; Tiedemann, K | 1 |
| Göeken, LN; Kamps, WA; Molenaar, WM; Postma, A; Schraffordt Koops, H; Veth, RP | 1 |
| Bonnet, F; Cany, L; Coindre, JM; de Mascarel, A; Robert, J; Vergier, B | 1 |
| Bloem, JL; Doornbos, J; Hermans, J; Holscher, HC; Nooy, MA; van der Woude, HJ | 1 |
| Bos, G; Brown, D; Fletcher, WS; Lebredo, L; Moseley, HS; Small, K; Woltering, EA | 1 |
| Bacci, G; Barbieri, E; Casadei, R; Fabbri, N; Ferrari, S; Ferraro, A; Mercuri, M; Picci, P; Rosito, P; Ruggieri, P | 1 |
| Dunst, J; Jürgens, H; Paulussen, M | 1 |
| Beaufort-Krol, GC; Bink-Boelkens, MT; Elzenga, NJ; Kamps, WA; Kengen, RA; Postma, A; Schasfoort-van Leeuwen, MJ; Schraffordt koops, H | 1 |
| Goorin, A; Hallowell, JA; Kharasch, VS; Lipsitz, S; Santis, W | 1 |
| Bacci, G; Barbieri, E; Brach del Prever, A; Campanacci, M; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P | 1 |
| Manna, A; Morandi, S; Porcellini, A; Sabattini, E | 1 |
| Hetzel, DJ; Mortel, R; Olt, GJ; Podczaski, ES; Singapuri, K; Sorosky, JI | 1 |
| Baum, ES; Betcher, DL; Ettinger, LJ; Huvos, AG; Kisker, CT; Krailo, MD; Makley, JT; Miser, JS; Nachman, JB; Provisor, AJ; Yunis, EJ | 1 |
| Denhardt, DT; Kageyama, R; Matsue, M; Noda, M | 1 |
| Bacci, G; Barbieri, E; Brach Del Prever, A; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P; Ruggieri, P | 1 |
| Brun, B; Cornille, H; Delepine, G; Delepine, N; Desbois, JC; Voisin, MC | 1 |
| Bullimore, JA; Cotterill, SJ; Craft, AW; Pearson, D | 1 |
| Kwon, HJ; Sawamura, M; Schreiber, SL; Shimada, J | 1 |
| Diesseroth, A; Glatstein, E; Glaubiger, D; Kinsella, TJ; Makuch, R; Pizzo, P; Waller, B | 1 |
| Bacci, G; Barbieri, E; Brach del Prever, A; Ferrari, S; Forni, C; Mercuri, M; Picci, P; Rosito, P; Tienghi, A | 1 |
| Drüeke, TB; Yaghoobian, J | 1 |
| Dunst, J | 1 |
| Casper, E; Gorlick, R; Healey, JH; Heller, G; Huvos, AG; Lane, J; Meyers, PA | 1 |
| Alvegård, TA; Elomaa, I; Monge, OR; Nilbert, M; Saeter, G; Wiebe, T | 1 |
| Donaldson, SS; Gilula, L; Glicksman, A; Laurie, F; Link, MP; Manning, J; Neff, J; Reinus, W; Shuster, JJ; Thompson, E; Torrey, M | 1 |
| Ahrens, S; Dunst, J; Harms, D; Jürgens, H; Paulussen, M; Rübe, C; Winkelmann, W; Zoubek, A | 1 |
| Ahrens, S; Dunst, J; Hillmann, A; Hofmann, J; Jürgens, H; Paulussen, M; Rübe, C; Schuck, A; Willich, N | 1 |
| Bacci, G; Barbieri, E; Cesari, M; Di Liddo, M; Ferrari, S; Longhi, A; Mancini, A; Mercuri, M; Rimondini, S; Rosito, P; Ruggieri, P | 1 |
| Bacci, G; Baldini, N; Barbieri, E; Cesari, M; Ferrari, S; Longhi, A; Mancini, AF; Mercuri, M; Picci, P; Rosito, P | 1 |
| Ahrens, S; Braun-Munzinger, G; Dunst, J; Göbel, U; Harms, D; Heinecke, A; Hoffmann, C; Jabar, S; Jürgens, H; Paulussen, M; Rübe, C; Treuner, J; Winkelmann, W; Winkler, K | 1 |
| Czyzewski, EA; Goldman, S; Hallahan, DE; Mundt, AJ; Nachman, J; Rubin, C | 1 |
| La Thangue, NB; Lee, CW | 1 |
| Bacchini, P; Bacci, G; Bertoni, F; Donati, D; Ferrari, S; Forni, C; Longhi, A; Manfrini, M; Picci, P; Rimondini, S | 1 |
| Bacchini, P; Bacci, G; Bertoni, F; Brach Del Prever, A; Donati, D; Ferrari, S; Forni, C; Longhi, A; Rimondini, S | 1 |
| Ashley, S; Atra, A; Cannon, S; Cotterill, SJ; Craft, AW; Grimer, R; Lewis, I; Pinkerton, CR; Shankar, AG; Spooner, D | 1 |
| Ben Abdallah, M; Ben Ayed, F; Ben Ghachem, M; Ben Hamida, H; Ben Hassine, H; Ben Romdhane, K; Boussen, H; Daldoul, O; Douik, M; Gamoudi, A; Karray, S; Khalfallah, S; Mezlini, A; Mezzi, F; Saadi, A | 1 |
| Brandao, L; Cain, AM; Kun, LE; McCarville, MB; Pappo, AS; Poquette, CA; Spunt, SL | 1 |
| Gebski, V; Machin, D; Tai, BC; White, I | 1 |
| Ahrens, S; Amann, G; Dockhorn-Dworniczak, B; Dunst, J; Exner, GU; Gadner, H; Göbel, U; Harms, D; Janka-Schaub, G; Jürgens, H; Kornhuber, B; Kotz, R; Müller-Weihrich, S; Paulussen, M; Treuner, J; Voûte, PA; Welte, K; Winkelmann, W; Zoubek, A | 1 |
| Agarwala, S; Bhatnagar, V; Gupta, AK; Hemal, AK; Mitra, DK; Seth, A | 1 |
| Ahrens, S; Aulitzky, WE; Dunst, J; Fölsch, UR; Göbel, U; Harms, D; Hense, HW; Henze, G; Jürgens, H; Kremens, B; Lehnert, M; Niemeyer, C; Paulussen, M; Reiter, A; Taeger, D; Voûte, PA; Wagner, A; Zoubek, A | 1 |
| Albrecht, RM; Bertics, PJ; Mellon, WS; Mosavin, R; Rivera-Bermúdez, MA | 1 |
| Mihova, A; Mumdjiev, I; Sokolov, T; Stoianova, A | 1 |
| Ahrens, S; Dunst, J; Jürgens, H; Könemann, S; Paulussen, M; Rübe, C; Rübe, CE; Schuck, A; Willich, N | 1 |
| Caparros, B; Gutierrez, M; Mosende, C; Rosen, G | 1 |
| Rosen, G | 3 |
| Blasková, L; Krizan, I; Krizan, Z; Látal, J; Majeský, B; Makai, F | 1 |
| Chan, RC; Johnston, DA; Lindberg, RD; Murray, JA; Samuels, ML; Sutow, WW | 1 |
| Hamdy, R | 1 |
| Gordon, RT; Hines, JR; Kolb, T; Widger, C | 1 |
| Afridi, MA; Douglass, H; Friedman, M; Wallace, JH | 1 |
| Cassady, RJ; Filler, RM; Jaffe, N; Murray, J; Traggis, D; Watts, H; Weichselbaum, R; Weinstein, H | 1 |
| Jaffe, N | 1 |
| Plager, C; Sinkovics, JG | 1 |
| Burgert, EO; Gehan, EA; Kissane, J; Nesbit, M; Perez, CA; Razek, A; Tefft, M; Vietti, T | 1 |
| Meuret, G | 1 |
| Chabora, BM; Rosen, G; Tefft, M | 1 |
| Kovacs, SG; Nathanson, L | 1 |
| Bonadonna, G; Fossati-Bellani, F; Gasparini, M | 1 |
| Bainvel, JV; Brossel, E; Dumont, J; Durant, D; Fumoleau, P; Garetta, M; Gimenez, M; Guerrin, D; Hoerni, B; Jasmin, C; Kenesi, C; Le Mevel, BP; Liegey-Bagari, D; Mazabraud, A; Rogez, JM; Salle, M; Sancho-Garnier, H; Tomend, B; Trifaud, A | 1 |
| Chabora, BM; Cham, W; D'Angio, GJ; Rosen, G; Tefft, M | 1 |
| Burgers, JM; van Dobbenburgh, OA; Voûte, PA | 1 |
| Cassady, JR; Jaffe, N; Paed, D; Salian, S; Traggis, D | 1 |
| Johnson, RE; Pomeroy, TC | 2 |
| Applewhite, A; Healey, J; Heller, G; Huvos, A; Lane, J; Marcove, R; Meyers, PA; Rosen, G; Vlamis, V | 1 |
| Black, T; Estrada-Aguilar, J; Greenberg, H; Hvizdala, E; Morse, S; Schroer, K; Walling, A | 1 |
| Gedikoğlu, G; Zülfikar, B | 1 |
| Blomqvist, C; Elomaa, I; Holmström, T; Karaharju, E; Laasonen, E; Ryöppy, S; Siimes, MA | 1 |
| Eldridge, RM; Fleming, RA; Johnson, CE; Stewart, CF | 1 |
| Glasser, DB; Lane, JM | 1 |
| Alvegård, TA; Elomaa, I; Holmström, T; Saeter, G; Solheim, OP; Stenwig, AE | 1 |
| Jurczyk-Procyk, S; Perek, D | 1 |
| Avella, M; Bacci, G; Barbieri, E; Battistini, A; Capanna, R; Casadei, R; Ferrari, S; Neri, S; Picci, P; Rosito, P | 1 |
| Ben-Arush, M; Bialik, V; Cohen, Y; Kuten, A; Perez-Nahum, M | 1 |
| Willnow, U | 1 |
| Raney, RB | 1 |
| Burgert, EO; Cangir, A; Evans, R; Garnsey, LA; Gehan, EA; Herrmann, J; Nesbit, ME; Tefft, M; Thomas, P; Vietti, TJ | 1 |
| Askin, FB; Burgert, EO; Cangir, A; Evans, R; Gehan, EA; Kissane, JM; Nesbit, ME; Tefft, M; Thomas, P; Vietti, TJ | 1 |
| Delling, G; Knop, J; Montz, R; Stritzke, P; Winkler, K | 1 |
| Delling, G; Hajek, P; Kotz, R; Kumpan, W; Lechner, G; Salzer-Kuntschik, M; Sekera, J; Wittich, GR | 1 |
| Huvos, AG; Marcove, R; Nirenberg, A; Rosen, G | 1 |
| Epelman, S; Jaffe, N; Pratt, CB | 1 |
| Dawson, P; Dean, L; Nachman, J; Shermeta, D; Simon, MA; Vogelzang, NJ | 1 |
| Bauters, F; Fenaux, P; Jouet, JP; Lai, JL; Lepelley, P | 1 |
| Berger, J; Beron, G; Delling, G; Gerein, V; Heise, U; Jürgens, H; Kabisch, H; Purfürst, C; Ritter, J; Winkler, K | 1 |
| Bachelot, C; Boitetot, A; Brunat-Mentigny, M; Demaille, MC; Gentet, JC; Noir, P; Olive, D; Quitana, E; Roche, H; Thyss, JP | 1 |
| Contesso, G; Dubousset, J; Kalifa, C; Lumbroso, J; Mlika, N; Vanel, D | 1 |
| Kettler, AH; Levy, ML; Scallan, PJ; Tschen, JA | 1 |
| Bielack, S; Delling, G; Knop, J; Winkler, K | 1 |
| Beppu, Y; Chuman, H; Fukuma, H | 1 |
| Baranzelli, MC; Bouretz, JC; Demaille, MC; Dusol, F; Gosselin, P | 1 |
| Brunat-Mentigny, M; Manoukian, A; Nourissat, C; Patricot, LM; Tachon, G | 1 |
| Exner, U; Göbel, U; Jürgens, H; Kühl, J; Ritter, J; Treuner, J; Weinel, P; Winkler, K | 1 |
| Behar, C; Benz-Lemoine, E; Boilletot, A; Brunat-Mentigny, M; Deméocq, F; Gentet, JC; Oberlin, O; Olive, D; Poutard, P; Zucker, JM | 1 |
| Egorov, LV; Perevodchikova, NI; Terent'eva, TG | 1 |
| Avioli, LV; Birge, SJ; Kim, YS; Miller, R | 1 |
| Adachi, N; Fukuma, H; Hanada, M; Ohira, M; Takayama, J | 1 |
| Austin, BA; Fleming, ID; Green, AA; Hayes, FA; Hustu, HO; Kumar, AP; Pate, JW; Rao, BN; Thompson, EI | 1 |
| Burgers, JM; Dunst, J; Hawlicek, R; Jürgens, H; Michaelis, J; Sauer, R | 1 |
| Avella, M; Baldini, N; Battistini, A; Boriani, S; Campanacci, M; Mancini, A; Monesi, M; Sudanese, A; Toni, A | 1 |
| Amino, K; Furuya, K; Isobe, Y; Kawaguchi, N; Manabe, J; Matsumoto, S | 1 |
| Delépine, G; Delépine, N; Desbois, JC; Legmann, F; Mathé, G | 1 |
| Claus, D; Cornu, G; Gosseye, S; Ninane, J; Panteon, E; Rombouts, JJ | 1 |
| Brunat-Mentigny, M; Demaille, MC; Demeocq, F; Lacombe, MJ; Lemerle, J; N'Guyen Bui, B; Oberlin, O; Patte, C; Tron, P | 1 |
| Askin, F; Burgert, O; Cangir, A; Evans, R; Foulkes, M; Gehan, E; Gilula, L; Kissane, J; Makley, J; Nesbit, M | 1 |
| Furuse, K; Maeyama, I; Morimoto, K; Orito, T | 1 |
| Friedman, B; Hanaoka, H | 1 |
| Fujimoto, T; Sutow, WW; Vietti, TJ; Vuthibhagdee, P; Watanabe, A; Wilbur, JR | 1 |
| Bhana, D; Kyalwazi, SK; Master, SP | 1 |
| Brunat, M; Dargent, M; Pommatau, E | 1 |
| Göbel, U; Niemann, F; Schacht, U; Schulz, RD | 1 |
| Akopiants, SM; Budkevich, IuV; Gorbunova, VA; Kuchkarev, RN; Titievskaia, VV | 1 |
| Breslow, N; Hartmann, JR; Heyn, RM; Holland, R; Newton, WA; Tefft, M | 1 |
| Plüss, HJ | 1 |
| Fernandez, CH; Gottlieb, JA | 1 |
| Borden, S; Toch, R; Wang, CC; Weber, AL | 1 |
| Cham, W; D'Angio, GJ; Hajdu, SI; Murphy, ML; Rosen, G; Tan, C; Wollner, N; Wu, SJ | 1 |
| McBride, CM | 1 |
| Hall, TC; Miller, S; Nathanson, L; Schilling, A | 1 |
| Tefft, M | 1 |
| Kyalwazi, SK; Taylor, JF; Templeton, AC; Templeton, CJ; Vogel, CL | 1 |
| Ekert, H; Finklestein, JZ; Higgins, G; Isaacs, H | 1 |
| Finklestein, JZ; Hastings, N; Hittle, R; Isaacs, H; Ortega, JA | 1 |
9 review(s) available for dactinomycin and Bone Cancer
| Article | Year |
|---|---|
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2019 |
[Soft tissue sarcoma: postoperative chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Melphalan; Mesna; Methotrexate; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2004 |
Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Germany; Humans; Ifosfamide; Immunologic Factors; Interferon-beta; Methotrexate; Multicenter Studies as Topic; Osteosarcoma; Prognosis; Randomized Controlled Trials as Topic; Treatment Outcome; Vincristine | 1993 |
Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; New York; Osteosarcoma; Prognosis; Proportional Hazards Models; Racial Groups; Retrospective Studies; Risk; Survival Rate; Treatment Outcome | 1993 |
[Therapy results of the British ET-1 study for Ewing's sarcoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Sarcoma, Ewing; Vincristine | 1998 |
[Therapy of sarcomas].
Topics: Adolescent; Adult; Bone Neoplasms; Child; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Methotrexate; Middle Aged; Osteosarcoma; Remission, Spontaneous; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 1978 |
Chemotherapy for children with aggressive fibromatosis and Langerhans' cell histiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Fibroma; Histiocytosis, Langerhans-Cell; Humans; Soft Tissue Neoplasms; Vincristine | 1991 |
[Importance of dactinomycin in the current therapy of tumors].
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Clinical Trials as Topic; Dactinomycin; Dogs; Drug Resistance; Dysgerminoma; Female; Humans; Kidney Neoplasms; Male; Melanoma; Neoplasms; Pregnancy; Sarcoma; Sarcoma, Kaposi; Soft Tissue Neoplasms; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms; Wilms Tumor | 1985 |
Proceedings: Recent progress in the chemotherapy of primary tumors of bone.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Humans; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1972 |
53 trial(s) available for dactinomycin and Bone Cancer
| Article | Year |
|---|---|
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 2023 |
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bone Neoplasms; Busulfan; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Melphalan; Sarcoma, Ewing; Vincristine | 2022 |
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Busulfan; Child; Child, Preschool; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Male; Middle Aged; Sarcoma, Ewing; Vincristine; Young Adult; Zoledronic Acid | 2020 |
Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Female; Humans; Japan; Male; Sarcoma, Ewing; Survival Rate; Vincristine | 2020 |
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Sarcoma, Ewing; Treatment Outcome; Vincristine; Young Adult | 2014 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Ifosfamide; Infant; Lung Neoplasms; Male; Neoplasm Staging; Prospective Studies; Sarcoma, Ewing; Vincristine | 2008 |
Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brachial Artery; Catheterization, Peripheral; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Infusions, Intra-Arterial; Male; Melanoma; Melphalan; Middle Aged; Popliteal Artery; Radiography, Interventional; Remission Induction; Sarcoma | 2009 |
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2009 |
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Sarcoma, Ewing; Vincristine; Young Adult | 2011 |
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine | 2003 |
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Survival Analysis; Treatment Outcome | 2003 |
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Pelvic Bones; Radiotherapy, Adjuvant; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2006 |
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Neural Tube Defects; Neuroectodermal Tumors, Primitive; Proportional Hazards Models; Risk; Sarcoma, Ewing; Vincristine | 2007 |
[Treatment of Ewing's sarcoma in children and adolescents: a cooperative study of the German society of pediatric oncology (author's transl)].
Topics: Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Prognosis; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 1981 |
Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Clinical Trials as Topic; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Interferons; Methotrexate; Osteosarcoma; Preoperative Care; Random Allocation | 1983 |
Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Humans; Interferon Type I; Male; Methotrexate; Osteosarcoma; Prognosis | 1984 |
[Treatment of Ewing's sarcoma with intensive initial chemotherapy. 1st evaluation of a French pediatric multicenter protocol].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Follow-Up Studies; Humans; Infant; Ribs; Sarcoma, Ewing; Time Factors; Vincristine | 1984 |
The role of radiation therapy in the management of non-metastatic Ewing's sarcoma of bone. Report of the Intergroup Ewing's Sarcoma Study.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Radiotherapy Dosage; Random Allocation; Sarcoma, Ewing; Vincristine | 1981 |
Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: an Intergroup Study.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Neoplasm Metastasis; Prognosis; Sarcoma, Ewing; Time Factors; Vincristine | 1981 |
Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Radiation; Doxorubicin; Drug Therapy, Combination; Female; Humans; Infant; Lung; Lung Neoplasms; Male; Neoplasm Metastasis; Sarcoma, Ewing; Vincristine | 1981 |
Metastatic sarcomas: chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristine.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Methotrexate; Neoplasm Metastasis; Pilot Projects; Prognosis; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1981 |
Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Male; Radiotherapy Dosage; Sarcoma, Ewing; Treatment Failure; Vincristine | 1995 |
The multi-institutional osteosarcoma study: an update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Life Tables; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; United States | 1993 |
Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; United States; Vincristine | 1993 |
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
Topics: Actuarial Analysis; Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Extremities; Female; Humans; Italy; Male; Methotrexate; Necrosis; Osteosarcoma; Prognosis; Salvage Therapy; Survival Analysis | 1993 |
Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Feasibility Studies; Female; France; Humans; Ifosfamide; Leucovorin; Male; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; Vincristine | 1993 |
Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Life Tables; Methotrexate; Osteosarcoma; Treatment Outcome; Vincristine | 1993 |
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Middle Aged; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1993 |
Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Extremities; Humans; Methotrexate; Osteosarcoma; Vincristine | 1997 |
Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Magnetic Resonance Imaging; Male; Multivariate Analysis; Prognosis; Sarcoma, Ewing; Tomography, X-Ray Computed; Vincristine | 1997 |
Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Leg; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Proportional Hazards Models; Risk Factors; Sarcoma, Ewing; Survival Analysis; Vincristine | 1997 |
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 1998 |
Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Methotrexate; Necrosis; Osteosarcoma; Time Factors; Treatment Outcome | 1998 |
A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Neoplasms, Second Primary; Radiotherapy Dosage; Remission Induction; Sarcoma, Ewing; Treatment Failure; Vincristine | 1998 |
Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Thorax; Vincristine | 1998 |
Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Prognosis; Sarcoma, Ewing; Vincristine | 1998 |
Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Male; Multivariate Analysis; Neoplasm Staging; Prognosis; Proportional Hazards Models; Regression Analysis; Sarcoma, Ewing; Survival Analysis; Vincristine | 1999 |
Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Proportional Hazards Models; Risk Assessment | 2001 |
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Europe; Humans; Ifosfamide; Incidence; Infant; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 2001 |
Analysis of local tumor control in Ewing's sarcoma: preliminary results of a cooperative intergroup study.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Radiation; Doxorubicin; Drug Therapy, Combination; Female; Humans; Infant; Lung Neoplasms; Male; Neoplasm Metastasis; Pelvic Neoplasms; Remission, Spontaneous; Sarcoma, Ewing; Time Factors; Vincristine | 1977 |
[Alternative chemotherapy of malignant bone neoplasms in children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Methotrexate; Organoplatinum Compounds; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1990 |
Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Humans; Infant; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Randomized Controlled Trials as Topic; Sarcoma, Ewing; Vincristine | 1990 |
Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Sarcoma, Ewing; Survival Rate; United States; Vincristine | 1990 |
Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Female; Humans; Male; Neoplasm Metastasis; Osteosarcoma | 1987 |
Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Postoperative Period; Preoperative Care; Prognosis; Random Allocation | 1988 |
[Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology].
Topics: Adolescent; Adult; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Follow-Up Studies; Humans; Methotrexate; Multicenter Studies as Topic; Osteosarcoma; Radionuclide Imaging; Technetium Tc 99m Medronate | 1988 |
Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results. A protocol of the French Pediatric Oncology Society (SFOP).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Dactinomycin; Doxorubicin; France; Humans; Ifosfamide; Medical Oncology; Pediatrics; Remission Induction; Sarcoma, Ewing; Societies, Medical; Vincristine | 1989 |
[Importance of dactinomycin in the current therapy of tumors].
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Clinical Trials as Topic; Dactinomycin; Dogs; Drug Resistance; Dysgerminoma; Female; Humans; Kidney Neoplasms; Male; Melanoma; Neoplasms; Pregnancy; Sarcoma; Sarcoma, Kaposi; Soft Tissue Neoplasms; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms; Wilms Tumor | 1985 |
Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Follow-Up Studies; Humans; Lung; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvic Bones; Radiotherapy Dosage; Random Allocation; Sarcoma, Ewing; Time Factors; Vincristine | 1985 |
Integrated therapy for Ewing's sarcoma.
Topics: Adolescent; Adult; Blood-Brain Barrier; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Female; Humans; Male; Neoplasm Metastasis; Radiotherapy, High-Energy; Sarcoma, Ewing; Time Factors; Vincristine | 1972 |
Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature.
Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Neoplasms; Carcinoma; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Drug Synergism; Female; Fluorouracil; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Melphalan; Middle Aged; Mitomycins; Parotid Neoplasms; Sarcoma; Urogenital Neoplasms; Vincristine | 1969 |
Treatment of Kaposi's sarcoma with actinomycin-D and cyclophosphamide: results of a randomized clinical trial.
Topics: Adult; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Sarcoma, Kaposi; Skin Neoplasms | 1971 |
141 other study(ies) available for dactinomycin and Bone Cancer
| Article | Year |
|---|---|
Fusion-negative rhabdomyosarcoma with diffuse bony metastases and remarkable chemosensitivity.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Genital Neoplasms, Male; Humans; Male; Rhabdomyosarcoma; Rhabdomyosarcoma, Embryonal; Tumor Lysis Syndrome; Vincristine | 2022 |
NMNAT1 Is a Survival Factor in Actinomycin D-Induced Osteosarcoma Cell Death.
Topics: Antibiotics, Antineoplastic; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Cell Proliferation; Dactinomycin; Gene Expression Regulation, Neoplastic; Humans; Nicotinamide-Nucleotide Adenylyltransferase; Osteosarcoma; Poly (ADP-Ribose) Polymerase-1; Sirtuin 1; Tumor Cells, Cultured | 2021 |
ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Bone Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dactinomycin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; HEK293 Cells; Hep G2 Cells; Humans; MCF-7 Cells; Neoplastic Stem Cells; Osteosarcoma; RNA, Messenger; Vincristine | 2019 |
Epigenetic control of endothelin-1 axis affects invasiveness of breast carcinoma cells with bone tropism.
Topics: Azacitidine; Bone Neoplasms; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Movement; Collagen; Dactinomycin; DNA Methylation; Drug Combinations; Endothelin A Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Laminin; Mutation; Neoplasm Invasiveness; Peptides, Cyclic; Proteoglycans; Proto-Oncogene Protein c-ets-1; Receptor, Endothelin A; RNA Stability; RNA, Messenger; Transcription, Genetic | 2013 |
Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Genotype; Humans; Male; Methotrexate; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Vincristine; Young Adult | 2013 |
Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Infant, Newborn; Lung Neoplasms; Male; Neoplasm Staging; Pediatrics; Poland; Postoperative Complications; Prognosis; Radiotherapy Dosage; Sarcoma, Ewing; Survival Rate; Vincristine; Young Adult | 2014 |
Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leukocyte Count; Male; Neoadjuvant Therapy; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine | 2015 |
Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bone Neoplasms; Child; Child, Preschool; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Infant; Japan; Lower Extremity; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Treatment Outcome; Upper Extremity; Vincristine; Young Adult | 2016 |
Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Butadienes; Cell Death; Cell Line, Tumor; Chromones; Dactinomycin; Drug Resistance, Neoplasm; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Morpholines; Nitriles; Oncogene Proteins, Fusion; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Protein c-fli-1; RNA-Binding Protein EWS; RNA, Small Interfering; Sarcoma, Ewing; Signal Transduction; Transcription Factors; Transfection | 2009 |
Extra-osseous Ewing sarcoma.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Child; Child, Preschool; Dactinomycin; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Prognosis; Protein Synthesis Inhibitors; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2009 |
Local and systemic control of Ewing's bone sarcoma family tumors of the ribs.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Plates; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fascia Lata; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Ribs; Sarcoma, Ewing; Surgical Mesh; Thoracotomy; Vincristine | 2009 |
Radiation toxicity following busulfan/melphalan high-dose chemotherapy in the EURO-EWING-99-trial: review of GPOH data.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cross-Sectional Studies; Dactinomycin; Dose-Response Relationship, Drug; Germany; Humans; Ifosfamide; Intestines; Lung; Melphalan; Multicenter Studies as Topic; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Registries; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Spinal Cord; Survivors; Vincristine | 2009 |
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2011 |
Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Infant; Kaplan-Meier Estimate; Leucovorin; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Survival Rate; Vincristine; Young Adult | 2011 |
Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2011 |
Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Doxorubicin; Etoposide; Female; Hamartoma; Humans; Ifosfamide; Liver Neoplasms; Mesoderm; Prognosis; Sarcoma, Ewing; Vincristine; Young Adult | 2013 |
Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cryopreservation; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Fertility Preservation; Follicle Stimulating Hormone; Humans; Ifosfamide; Ovary; Primary Ovarian Insufficiency; Prognosis; Puberty; Radiotherapy, Conformal; Sarcoma, Ewing; Vincristine | 2013 |
Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cyclophosphamide; Dactinomycin; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Endonucleases; Female; Glutathione S-Transferase pi; Humans; Male; Methotrexate; Neoplasm Staging; Osteosarcoma; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prognosis; Survival Rate; Vincristine; Xeroderma Pigmentosum Group D Protein; Young Adult | 2012 |
Successful management of a child with clear cell sarcoma of the kidney (CCSK) and multifocal bone metastases at diagnosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Drug Administration Schedule; Female; Hematopoietic Stem Cell Mobilization; Humans; Kidney Neoplasms; Radiotherapy, Adjuvant; Sarcoma, Clear Cell; Vincristine | 2003 |
THE THERAPY OF SARCOMAS BY ISOLATION PERFUSION.
Topics: Aorta; Aorta, Abdominal; Bone Neoplasms; Carotid Arteries; Chemotherapy, Cancer, Regional Perfusion; Chondrosarcoma; Dactinomycin; Dogs; Fibrosarcoma; Iliac Artery; Iliac Vein; Leiomyosarcoma; Liposarcoma; Lymphoma, Non-Hodgkin; Melphalan; Mesothelioma; Neoplasms; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Kaposi; Subclavian Artery; Vena Cava, Inferior | 1964 |
INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
Topics: Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Female; Floxuridine; Fluorouracil; Genital Neoplasms, Female; Humans; In Vitro Techniques; Intestinal Neoplasms; Leukemia; Mechlorethamine; Melanoma; Mercaptopurine; Methotrexate; Neoplasms; Pharyngeal Neoplasms; Respiratory Tract Neoplasms; Stomach Neoplasms; Thiotepa | 1964 |
OSTEOGENIC SARCOMA OF THE MANDIBLE. REPORT OF CASE TREATED BY RADIATION AND CHEMOTHERAPY.
Topics: Bone Neoplasms; Cobalt Isotopes; Dactinomycin; Drug Therapy; Humans; Mandible; Mandibular Neoplasms; Melphalan; Methotrexate; Neoplasms; Osteomyelitis; Osteosarcoma; Pathology; Radiography; Radium; Sarcoma | 1964 |
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Treatment Failure; Vincristine | 2004 |
Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dexamethasone; Etoposide; Female; Fetus; Humans; Ifosfamide; Infant, Newborn; Kidney Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Neoplasm Recurrence, Local; Patient Dropouts; Polyradiculopathy; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Spinal Cord Compression; Vincristine; Wilms Tumor | 2004 |
Cisplatin-induced hypomagnesemia and cardiac dysrhythmia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Gastroenteritis; Heart Arrest; Humans; Magnesium; Methotrexate; Osteosarcoma; Water-Electrolyte Imbalance | 2007 |
Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, High-Energy; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; United States; Vincristine | 2007 |
[Acquired Fanconi-de Toni-Debre syndrome due to therapy for Ewing's sarcoma in 5-years old boy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Dactinomycin; Doxorubicin; Etoposide; Fanconi Syndrome; Femur; Humans; Ifosfamide; Male; Sarcoma, Ewing; Vincristine | 2006 |
Temporal bone rhabdomyosarcoma presenting as acute peripheral facial nerve paralysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Facial Nerve Diseases; Facial Paralysis; Female; Humans; Magnetic Resonance Imaging; Radiotherapy; Rhabdomyosarcoma; Temporal Bone; Vincristine | 2006 |
Primary rhabdomyosarcoma of the breast in a 13-year-old girl: report of a case.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dactinomycin; Doxorubicin; Fatal Outcome; Female; Humans; Ifosfamide; Lung Neoplasms; Mastectomy; Rhabdomyosarcoma, Alveolar | 2007 |
Local and distant control in non-metastatic pelvic Ewing's sarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Humans; Ilium; Male; Middle Aged; Pelvic Bones; Sarcoma, Ewing; Survival Analysis; Vincristine | 2007 |
Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Netherlands; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Contraindications; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Extremities; Female; Humans; Limb Salvage; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Treatment Outcome | 2007 |
Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines.
Topics: Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dactinomycin; Humans; Nucleic Acid Synthesis Inhibitors; Osteosarcoma; Retinoblastoma Protein; Ribosomes; RNA Interference; RNA, Ribosomal; Tumor Suppressor Protein p53 | 2007 |
[Preoperative adjuvant therapy for primary malignant bone tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2007 |
[Initial chemotherapy and conservative surgery in the current treatment of osteosarcoma. Apropos of 24 cases].
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methods; Methotrexate; Osteosarcoma; Vincristine | 1984 |
Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
Topics: Antineoplastic Agents; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Leucovorin; Methotrexate; Osteosarcoma; Prognosis; Time Factors | 1982 |
[Ewing's sarcoma: therapeutic experience (author's transl)].
Topics: Adolescent; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Preoperative Care; Sarcoma, Ewing; Vincristine | 1982 |
[Evaluation of the results of treatment of endodermal sinus tumor in children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Coccyx; Combined Modality Therapy; Dactinomycin; Female; Follow-Up Studies; Genital Neoplasms, Female; Humans; Infant; Male; Mesonephroma; Methotrexate; Radiotherapy Dosage; Sacrum; Testicular Neoplasms; Vincristine | 1984 |
Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. A report from the intergroup rhabdomyosarcoma study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Extremities; Female; Humans; Infant; Male; Prognosis; Registries; Rhabdomyosarcoma; Time Factors; Vincristine | 1984 |
Thymic enlargement following chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Humans; Humerus; Male; Sarcoma, Ewing; Thymus Hyperplasia; Tomography, X-Ray Computed; Vincristine | 1984 |
Ewing's sarcoma: A combined approach in the management.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Radiotherapy Dosage; Sarcoma, Ewing | 1981 |
A phase II evaluation of methyl CCNU and actinomycin D in the treatment of advanced sarcomas in adults.
Topics: Adult; Aged; Bone Neoplasms; Dactinomycin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nitrosourea Compounds; Sarcoma; Semustine; Soft Tissue Neoplasms | 1981 |
[On the chemotherapy of Ewing's sarcoma (author's transl)].
Topics: Bone Neoplasms; Cyclophosphamide; Dactinomycin; Humans; Lung Neoplasms; Sarcoma, Ewing; Vincristine | 1981 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine | 1994 |
A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Methotrexate; Middle Aged; Osteosarcoma; Pilot Projects; Remission Induction; Salvage Therapy; Treatment Outcome; Vincristine | 1993 |
Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leucovorin; Life Tables; Male; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; Victoria; Vincristine | 1993 |
Expression of MDR1/P glycoprotein in human sarcomas.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Carrier Proteins; Dactinomycin; Drug Resistance; Gene Expression; Hemangiosarcoma; Histiocytoma, Benign Fibrous; Histocytochemistry; Humans; Immunoblotting; In Situ Hybridization; Leiomyosarcoma; Liposarcoma; Membrane Glycoproteins; Neoplasm Proteins; Podophyllotoxin; Rhabdomyosarcoma; RNA, Messenger; RNA, Neoplasm; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Tumor Cells, Cultured; Vinca Alkaloids | 1993 |
Magnetic resonance relaxation times of normal tissue in the course of chemotherapy: a study in patients with bone sarcoma.
Topics: Adipose Tissue; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Muscles; Osteosarcoma; Preoperative Care; Sarcoma, Ewing; Vincristine | 1994 |
Hyperthermic isolation limb perfusion (HILP) in the management of extremity melanoma and sarcoma with particular reference to the dosage, pharmacokinetics, and toxicity of cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Dacarbazine; Dactinomycin; Evaluation Studies as Topic; Extremities; Humans; Hyperthermia, Induced; Incidence; Melanoma; Melphalan; Neoplasm Metastasis; Osteosarcoma; Rhabdomyolysis; Skin Neoplasms; Treatment Outcome | 1993 |
Lung irradiation for Ewing's sarcoma with pulmonary metastases at diagnosis: results of the CESS-studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Germany; Humans; Ifosfamide; Lung Neoplasms; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 1993 |
Late cardiotoxicity after treatment for a malignant bone tumor.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Bleomycin; Body Surface Area; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Dilatation, Pathologic; Doxorubicin; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart; Heart Diseases; Heart Rate; Humans; Male; Methotrexate; Middle Aged; Myocardium; Radionuclide Angiography; Stroke Volume; Survivors; Ventricular Dysfunction, Left | 1996 |
Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Forced Expiratory Volume; Humans; Lung; Methotrexate; Osteosarcoma; Pulmonary Diffusing Capacity; Total Lung Capacity | 1996 |
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 1995 |
Rhabdomyosarcoma presenting as acute leukemia.
Topics: Acute Disease; Adolescent; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Doxorubicin; Female; Humans; Leukemia; Neoplasm Metastasis; Recurrence; Rhabdomyosarcoma; Vincristine | 1996 |
Gestational trophoblastic disease presenting as a large metastasis to the finger.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Fingers; Humans; Leucovorin; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1996 |
Helix-loop-helix-type transcription factor (HES-1) is expressed in osteoblastic cells, suppressed by 1,25(OH)2 vitamin D3, and modulates 1,25(OH)2 vitamin D3 enhancement of osteopontin gene expression.
Topics: Animals; Blotting, Northern; Bone Neoplasms; Calcitriol; Cell Adhesion; Cell Division; Cycloheximide; Dactinomycin; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Neoplastic; Helix-Loop-Helix Motifs; Nucleic Acid Synthesis Inhibitors; Osteoblasts; Osteopontin; Osteosarcoma; Protein Synthesis Inhibitors; Rats; RNA, Messenger; Sialoglycoproteins; TCF Transcription Factors; Transcription Factor 7-Like 1 Protein; Transcription Factors; Tumor Cells, Cultured; Up-Regulation | 1997 |
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leg; Male; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine | 1997 |
Synthesis and cellular characterization of the detransformation agent, (-)-depudecin.
Topics: 3T3 Cells; Actins; Alkadienes; Animals; Bone Neoplasms; Cell Nucleus; Cell Transformation, Neoplastic; Cycloheximide; Cytoskeleton; Dactinomycin; Epoxy Compounds; Fatty Alcohols; Genes, ras; Magnetic Resonance Spectroscopy; Mice; Osteosarcoma; Protein Synthesis Inhibitors; Signal Transduction; Spectrophotometry, Infrared; Stereoisomerism; Tumor Cells, Cultured | 1995 |
Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine; Whole-Body Irradiation | 1983 |
Regulation of the transcription of parathyroid-hormone/parathyroid-hormone-related peptide receptor mRNA by dexamethasone in ROS 17/2.8 osteosarcoma cells.
Topics: Animals; Antineoplastic Agents, Hormonal; Bone Neoplasms; Cycloheximide; Dactinomycin; Dexamethasone; Half-Life; Osteosarcoma; Parathyroid Hormone-Related Protein; Protein Biosynthesis; Protein Synthesis Inhibitors; Proteins; Rats; Receptors, Parathyroid Hormone; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1998 |
Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Orthopedic Procedures; Radiotherapy, Adjuvant; Sarcoma, Ewing; Scandinavian and Nordic Countries; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Radiotherapy Dosage; Sarcoma; Sarcoma, Ewing; Time Factors; Vincristine | 1998 |
Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Staging; Predictive Value of Tests; Sarcoma, Ewing; Vincristine | 1998 |
Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy Dosage; Retrospective Studies; Salvage Therapy; Sarcoma; Treatment Failure; Vincristine; Whole-Body Irradiation | 1999 |
Promoter specificity and stability control of the p53-related protein p73.
Topics: Adenovirus E1A Proteins; Bone Neoplasms; Cysteine Endopeptidases; Dactinomycin; DNA-Binding Proteins; GADD45 Proteins; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Genes, myc; Genes, p53; Genes, Reporter; Genes, Tumor Suppressor; Humans; Intracellular Signaling Peptides and Proteins; Multienzyme Complexes; Multigene Family; Neoplasm Proteins; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Osteosarcoma; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Protein Isoforms; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Proto-Oncogene Proteins p21(ras); Recombinant Fusion Proteins; RNA Splicing; Sequence Deletion; Trans-Activators; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 1999 |
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Italy; L-Lactate Dehydrogenase; Male; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Retrospective Studies; Sarcoma, Ewing; Vincristine | 2000 |
Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chi-Square Distribution; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Survival Rate; Treatment Outcome; Vincristine | 2000 |
Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sarcoma, Ewing; Treatment Outcome; Vincristine | 1999 |
[Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
Topics: Adolescent; Adult; Alkaline Phosphatase; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Magnetic Resonance Imaging; Male; Methotrexate; Osteosarcoma; Prospective Studies; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 2000 |
Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Radiation Pneumonitis; Radiotherapy; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Infant; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Risk Factors; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Transitional cell carcinoma of the urinary bladder following exposure to cyclophosphamide in childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Transitional Cell; Combined Modality Therapy; Cyclophosphamide; Cystoscopy; Dactinomycin; Follow-Up Studies; Humans; Male; Monitoring, Physiologic; Radiography; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Vincristine | 2001 |
1,25-Dihydroxyvitamin D3 selectively translocates PKCalpha to nuclei in ROS 17/2.8 cells.
Topics: Blotting, Northern; Bone Neoplasms; Calcitriol; Calcium Channel Agonists; Cell Nucleus; Dactinomycin; Fluorescent Antibody Technique; Gene Expression; Humans; Immunoblotting; Isoenzymes; Osteocalcin; Osteosarcoma; Protein Kinase C; Protein Kinase C-alpha; RNA, Messenger; Subcellular Fractions; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured | 2002 |
[Treatment of Ewing's sarcoma with 2 different protocols].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Male; Prognosis; Radiotherapy; Sarcoma, Ewing; Survival Rate; Vincristine | 2001 |
Postoperative radiotherapy in the treatment of Ewing tumors: influence of the interval between surgery and radiotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Data Interpretation, Statistical; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Pilot Projects; Postoperative Care; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Time Factors; Vincristine | 2002 |
Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma.
Topics: Adolescent; Bleomycin; Bone Marrow; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Osteosarcoma; Vomiting | 1977 |
Malignant bone tumors: spindle-cell sarcomas.
Topics: Adolescent; Amputation, Surgical; Bleomycin; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Humans; Leucovorin; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Preoperative Care; Prostheses and Implants; Radiography; Vincristine | 1978 |
Malignant small-cell sarcomas of bone.
Topics: Adolescent; Bleomycin; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Metastasis; Radiography; Radiotherapy, High-Energy; Sarcoma, Ewing; Vincristine | 1978 |
[Cytostatic treatment as supplement in osteosarcoma and Ewing's sarcoma. Preliminary communication (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Humans; Long-Term Care; Male; Osteosarcoma; Prognosis; Sarcoma, Ewing; Vincristine | 1979 |
Management and results of localized Ewing's sarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Cobalt Radioisotopes; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Radiotherapy, High-Energy; Sarcoma, Ewing; Vincristine | 1979 |
The signs and treatment of Paget's disease.
Topics: Bone and Bones; Bone Neoplasms; Calcitonin; Dactinomycin; Diphosphonates; Femur; Fractures, Bone; Humans; Neurocognitive Disorders; Osteitis Deformans; Osteoblasts; Pain; Plicamycin; Radiography; Skull; Spine; Stress, Mechanical; Tibia | 1977 |
Cystosarcoma phyllodes metastatic to a brenner tumor of the ovary.
Topics: Bone Neoplasms; Brenner Tumor; Dactinomycin; Female; Humans; Mastectomy; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Phyllodes Tumor; Vincristine | 1976 |
Simultaneous radiation and drug therapy: tumor response and toxicity.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Doxorubicin; Female; Humans; Male; Neoplasms; Osteosarcoma; Radiotherapy; Rhabdomyosarcoma; Soft Tissue Neoplasms; Vincristine | 1977 |
Multidisciplinary treatment for childhood sarcoma.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Lymphatic Metastasis; Male; Methods; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 1977 |
Current concepts in the management of disseminated malignant bone disease in childhood.
Topics: Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Methotrexate; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1977 |
Bone sarcomas: clinical experience.
Topics: Age Factors; Bone Neoplasms; Chondrosarcoma; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1977 |
Radiation in bone sarcomas: a re-evaluation in the era of intensive systemic chemotherapy.
Topics: Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Radiation Tolerance; Radiotherapy Dosage; Radiotherapy, High-Energy; Sarcoma, Ewing; Vincristine | 1977 |
Chemotherapeutic response in metastatic medulloblastoma: report of two cases and a review of the literature.
Topics: Adolescent; Adult; Bone Neoplasms; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Medulloblastoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Semustine; Vincristine | 1978 |
Current results with a combined treatment approach to localized Ewing's sarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Sarcoma, Ewing; Vincristine | 1978 |
EORTC/GTO adjuvant chemotherapy program for primary Ewing's sarcoma: results at 5 years.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Methotrexate; Procarbazine; Sarcoma, Ewing; Vincristine | 1978 |
Radiotherapy of Ewing's sarcoma. Local control with and without intensive chemotherapy.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Radiotherapy, High-Energy; Sarcoma, Ewing; Vincristine | 1976 |
[Ewing's sarcoma in children; results of treatment in 11 children].
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Dactinomycin; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Remission, Spontaneous; Sarcoma, Ewing; Vincristine | 1977 |
Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy.
Topics: Adolescent; Bone Neoplasms; Boston; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Humans; Lung Neoplasms; Neoplasm Metastasis; Sarcoma, Ewing; Vincristine | 1976 |
Management of malignant bone tumors in children and adolescents.
Topics: Adolescent; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Neoplasm Metastasis; Osteosarcoma; Prognosis; Sarcoma, Ewing; Vincristine | 1976 |
Evaluation of therapeutic results in Ewing's sarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Extremities; Female; Humans; Infant; Infant, Newborn; Male; Mandibular Neoplasms; Methotrexate; Pelvic Bones; Ribs; Sarcoma, Ewing; Scapula; Sternum; Vincristine | 1975 |
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Proportional Hazards Models; Risk Factors; Survival Analysis | 1992 |
Primary treatment of pelvic osteosarcoma. Report of five cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fluid Therapy; Follow-Up Studies; Humans; Ifosfamide; Injections, Intra-Arterial; Lung Neoplasms; Osteosarcoma; Pelvic Bones; Radiotherapy Dosage; Survival Rate | 1992 |
Ewing's sarcoma: experience with 12 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1992 |
Ten years' experience in patients with osteogenic sarcoma in Finland.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Finland; Humans; Male; Methotrexate; Osteosarcoma; Survival Rate | 1990 |
Disposition of high-dose methotrexate in an obese cancer patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Half-Life; Humans; Leucovorin; Methotrexate; Obesity; Osteosarcoma; Tibia; Vincristine | 1991 |
Stage IIB osteogenic sarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Clinical Protocols; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; New York City; Osteosarcoma; Osteotomy; Postoperative Care; Predictive Value of Tests; Preoperative Care; Survival Analysis; Survival Rate | 1991 |
Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leg; Male; Methotrexate; Osteosarcoma; Survival Analysis | 1991 |
Non-metastatic Ewing's sarcoma: results in 98 patients treated with neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Infant; Lung Neoplasms; Male; Middle Aged; Sarcoma, Ewing; Vincristine | 1991 |
Results of multimodal therapy in Ewing's sarcoma: a retrospective analysis of 20 patients.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Recurrence, Local; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Vincristine | 1991 |
[Effect by proliferation kinetics of malignant tumors of children of hyperthermia].
Topics: Autoradiography; Bone Neoplasms; Cell Division; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Hot Temperature; Humans; In Vitro Techniques; Kidney Neoplasms; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Thymidine; Tritium; Uridine; Wilms Tumor | 1990 |
[Bone scintigraphy in assessing the success of chemotherapy in osteosarcoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone and Bones; Bone Neoplasms; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Diphosphonates; Drug Evaluation; Female; Humans; Male; Osteosarcoma; Preoperative Care; Radionuclide Imaging; Technetium; Technetium Tc 99m Medronate; Time Factors | 1985 |
The angiographic response of osteosarcoma following pre-operative chemotherapy.
Topics: Adolescent; Adult; Angiography; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Preoperative Care; Vincristine | 1986 |
Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma | 1986 |
Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Necrosis; Osteosarcoma; Postoperative Care; Preoperative Care; Vincristine | 1987 |
Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Methotrexate; Neoplasms, Multiple Primary; Osteosarcoma; Translocation, Genetic | 1987 |
[The reproduction in France of Rosen's protocol for osteosarcomas].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Prognosis | 1988 |
[Experience with protocol T10 in the pediatric service at the Gustave-Roussy Institute].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Humans; Infant; Male; Methotrexate; Osteosarcoma; Prognosis | 1988 |
Neutrophilic eccrine hidradenitis. Evidence implicating bleomycin as a causative agent.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Eccrine Glands; Female; Humans; Inflammation; Neutrophils; Osteosarcoma; Sweat Gland Diseases | 1988 |
[Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Male; Methotrexate; Osteosarcoma; Premedication | 1989 |
[Mirror-image osteosarcoma of the radius. A case].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Methotrexate; Neoplasms, Multiple Primary; Osteosarcoma; Prognosis; Radius | 1989 |
[Desmoid fibroma of the scapula. Recurrence with pulmonary metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Female; Fibroma; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Recurrence, Local; Scapula; Tamoxifen; Vincristine | 1989 |
High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 1989 |
Early manifestations of vitamin D effects in rat osteogenic sarcoma cells.
Topics: Animals; Bone Neoplasms; Calcitriol; Calcium; Cell Count; Cell Line; Dactinomycin; Dose-Response Relationship, Drug; Osteosarcoma; Rats; Tumor Cells, Cultured | 1987 |
[Autologous bone marrow transplantation in osteosarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Melphalan; Methotrexate; Osteosarcoma; Transplantation, Autologous | 1987 |
Chest wall resection for Ewing's sarcoma of the rib: an unnecessary procedure.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Radiography; Remission Induction; Ribs; Sarcoma, Ewing; Vincristine | 1988 |
Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Male; Prognosis; Sarcoma, Ewing; Vincristine | 1987 |
[Therapy of non-metastatic Ewing's sarcoma (pelvis excluded). Results obtained in 48 cases combining local therapy (radiation and/or surgical) and adjuvant chemotherapy with vincristine, adriamycin, dactinomycin and cyclophosphamide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Neoplasm Metastasis; Radiography; Sarcoma, Ewing; Vincristine | 1987 |
[Combination chemotherapy including cis-platinum in Ewing's sarcoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Male; Sarcoma, Ewing; Vincristine | 1987 |
[Objective response of desmoid fibroma to chemotherapy].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Drug Tolerance; Fibroma; Humans; Ifosfamide; Knee Joint; Scapula; Vincristine | 1987 |
Congenital fibrosarcoma. Preoperative chemotherapy and conservative surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Fibrosarcoma; Humans; Infant, Newborn; Male; Ribs; Soft Tissue Neoplasms; Vincristine | 1986 |
The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dexamethasone; Doxorubicin; Humans; Prognosis; Prospective Studies; Sarcoma, Ewing; Vincristine | 1985 |
[Preoperative adjuvant chemotherapy of skeletal and soft tissue sarcomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Preoperative Care; Radiography; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1985 |
Round-cell sarcomas of bone. A light and electron microscopic study.
Topics: Adolescent; Adrenal Gland Neoplasms; Aged; Bone Neoplasms; Catecholamines; Child; Child, Preschool; Dactinomycin; Female; Fibula; Glycogen; Humans; Humerus; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Microscopy, Electron; Middle Aged; Neuroblastoma; Pelvic Neoplasms; Reticulin; Sarcoma, Ewing; Staining and Labeling; Sternum; Vincristine | 1971 |
Evaluation of dosage schedules of mitomycin C (NSC-26980) in children.
Topics: Adolescent; Anemia; Bone Neoplasms; Brain Neoplasms; Child; Cyclophosphamide; Dactinomycin; Evaluation Studies as Topic; Female; Humans; Injections, Intravenous; Leukopenia; Male; Mitomycins; Neoplasm Metastasis; Neoplasms; Neurofibroma; Orbital Neoplasms; Rhabdomyosarcoma; Sarcoma; Thrombocytopenia; Vincristine | 1971 |
Actinomycin D in malignant Kaposi's sarcoma.
Topics: Adult; Aged; Bone Neoplasms; Dactinomycin; Drug Eruptions; Female; Foot Diseases; Hand; Humans; Lymph Nodes; Male; Middle Aged; Nausea; Sarcoma, Kaposi; Skin Neoplasms; Stomatitis; Thigh; Triaziquone; Vomiting | 1971 |
[Apropos of an experience with the polychemotherapy of cancer].
Topics: Adult; Bone Neoplasms; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Synergism; Dysgerminoma; Female; Fibrosarcoma; Humans; Male; Melanoma; Mesothelioma; Methotrexate; Middle Aged; Myxosarcoma; Neoplasms, Connective Tissue; Neoplasms, Germ Cell and Embryonal; Neurilemmoma; Neurofibromatosis 1; Ovarian Neoplasms; Rhabdomyosarcoma; Testicular Neoplasms; Uterine Neoplasms | 1968 |
[Wilm's tumors, neuroblastomas and bone neoplasms in childhood].
Topics: Bone Neoplasms; Child; Child, Preschool; Dactinomycin; Female; Humans; Infant; Kidney Neoplasms; Male; Neoplasm Metastasis; Neuroblastoma; Prognosis; Retrospective Studies; Wilms Tumor | 1971 |
[Results of cooperative clinical studies of the antineoplastic antibiotic dactinomycin].
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Choriocarcinoma; Dactinomycin; Female; Hodgkin Disease; Humans; Infant; Laryngeal Neoplasms; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Middle Aged; Pregnancy; Urinary Bladder Neoplasms; Uterine Neoplasms; Wilms Tumor | 1972 |
The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children.
Topics: Adolescent; Age Factors; Bone Neoplasms; Child; Child, Preschool; Dactinomycin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Infant; Lung Neoplasms; Lymph Nodes; Male; Neoplasm Metastasis; Remission, Spontaneous; Rhabdomyosarcoma; Time Factors; Vincristine | 1974 |
[Chemotherapy of bone tumors].
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1973 |
Pineal germinoma. Long-term survival despite hematogenous metastases.
Topics: Bone Neoplasms; Carotid Arteries; Cerebral Angiography; Cerebral Ventricle Neoplasms; Cerebrospinal Fluid Shunts; Cervical Vertebrae; Child; Cyclophosphamide; Dactinomycin; Electroencephalography; Femur; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Pinealoma; Pneumoencephalography; Postoperative Complications | 1973 |
Proceedings: Disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy.
Topics: Adolescent; Age Factors; Bone Neoplasms; Child; Child, Preschool; Cobalt Radioisotopes; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Femoral Neoplasms; Follow-Up Studies; Heart; Heart Failure; Humans; Male; Radioisotope Teletherapy; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 1974 |
Sarcomas of the limbs. Results of adjuvant chemotherapy using isolation perfusion.
Topics: Aged; Amputation, Surgical; Arm; Bone Neoplasms; Cartilage; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Female; Fibrosarcoma; Hemangiosarcoma; Humans; Leg; Liposarcoma; Male; Melphalan; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sarcoma | 1974 |
Advanced, recurrent and-or unusual metastases in childhood malignancies. Illustrations of a "philosophical" approach to the use of radiation therapy.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Humans | 1971 |
Bone marrow metastases in children with solid tumors.
Topics: Bone Marrow Diseases; Bone Marrow Examination; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Ganglioneuroma; Humans; Mechlorethamine; Neoplasm Metastasis; Neuroblastoma; Prednisone; Retinoblastoma; Rhabdomyosarcoma; Sarcoma; Streptonigrin; Vincristine | 1970 |
Chemotherapy of malignant hemangiopericytoma of childhood. Report of a case and review of the literature.
Topics: Biopsy; Bone Neoplasms; Child, Preschool; Cyclophosphamide; Dactinomycin; Hemangiopericytoma; Humans; Laparotomy; Male; Methotrexate; Neoplasm Metastasis; Radiography; Retroperitoneal Neoplasms; Vincristine | 1971 |